Main navigation | Main content
The conduct of research is deeply connected to the university's mission. It is of critical importance to the reputation and future of this institution that we remain committed to the highest standards of research integrity in all work conducted in our institution.
Human Research Protection Program (HRPP) staff process IRB and IBC submissions, assist independent research review committees, and assist executive committees comprised of chairs and vice-chairs from other panels.
The Institutional Biosafety Committee (IBC) reviews projects working with Recombinant DNA, Synthetic Nucleic Acid Molecules, Artificial Gene Transfer, Infectious Agents (bacteria, viruses, protozoans, fungi, etc.) and Biologically Derived Toxins. The IBC committee meets monthly to review research and related issues.
The Institutional Review Board (IRB) reviews human subjects’ research projects, working with investigators to ensure adequate protection and informed, uncoerced consent. Human medical research studies go before the committee five times each month, faculty social research is reviewed monthly, and student social research studies are reviewed monthly.
HRPP facilitates scientific assessment of new biomedical research proposals.This assessment may be used to fulfill the scientific review requirement when submitting applications for full committee medical reviews to the IRB.
More information about the IRB’s scientific review requirements, including other options for meeting these requirements, may be found here.
An external review of clinical research involving human subjects at the University of Minnesota has just been released.
IRB now allows researcher attendance at committee meetings at which the PI's study is under review.
Updates for IRB biomedical applications:
All new and three year renewal IBC applications must be submitted using eProtocol
OVPR launches new site to explore the impact of research on our world: